摘要
目的:探讨患者植入动脉导管药盒系统(implantable reservoir port and catheter connecting system,PCS)后行药物灌注治疗,发生菌血症的原因。方法:对163例行动脉导管药盒系统植入后进行药物灌注治疗的中晚期肿瘤患者进行多因素回顾分析、总结。结果:163例中晚期肿瘤患者行动脉导管药盒系统植入后进行药物灌注治疗,有14例发生菌血症。菌血症的发生与合并肝硬化、糖尿病、药盒皮囊积血、穿刺针留置时间等因素有关。结论:多因素分析可减少经皮动脉导管药盒系统药物灌注治疗的并发症。
Objective：To study the cause of bacteremia of patients who were treated by PCS. Methods： Multivariate analysis of data of 163 patients with advanced turnout who were treated by PCS. Results： Of 163 patients, 14 patients had bacteremia after PCS treatment. There was a closely correlation between bacteremia and cirrhosis and diabetes mellitus and extravasated blood and the detaining time of arterial cannula. Conclusion： Multivariate analysis of clinical data can reduce complications of patients who were treated by PCS.
出处
《中国医药导报》
CAS
2011年第12期185-185,188,共2页
China Medical Herald
关键词
导管药盒系统
菌血症
并发症
Port-catheter system
Bacteremia
Complications
